Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2006
01/05/2006US20060003387 Cell display libraries
01/05/2006US20060003385 Mass intensity profiling system and uses thereof
01/05/2006US20060003383 Fluorogenic enzyme activity assay methods and compositions using fragmentable linkers
01/05/2006US20060003380 Human tumor necrosis factor receptor TR-17
01/05/2006US20060003379 Smad6 and uses thereof
01/05/2006US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics
01/05/2006US20060003377 Therapeutic and diagnostic proteins comprising a SOCS box
01/05/2006US20060003376 Non-destructive quality control method for microarray substrate coatings via labeled doping
01/05/2006US20060003375 Novel polypeptide - human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same
01/05/2006US20060003374 Coupling amine terminated PNA oligomer or an amine terminated cleavable linker on a solid phase synthesis resin with a benzothiole-2-sulfonyl derivative, capping unprotected amine with actetic anhydride, cleaving over reacted acetyl group, deprotecting benzothiole-2-sulfonyl group, repeating above steps
01/05/2006US20060003373 Automated process for isolating and amplifying a target nucleic acid sequence
01/05/2006US20060003372 Integration of direct binding label-free biosensors with mass spectrometry for functional and structural characterization of molecules
01/05/2006US20060003371 Methods and reagents for improved selection of biological molecules
01/05/2006US20060003370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/05/2006US20060003369 Provision of DNA investigating tools
01/05/2006US20060003368 Nicotinamide N-methyltransferase as a marker for colorectal cancer
01/05/2006US20060003367 Polynucleotides encoding a novel human Kupffer cell receptor protein, BGS-18
01/05/2006US20060003366 Multiplexing assays for analyte detection
01/05/2006US20060003365 profiling in multiple myeloma patients identifies genes that distinguish between patients with subsequent early death or long survival after treatment; using ASPM, OPN3 and CKS1B genes as biomarkers
01/05/2006US20060003364 GLUT1 transporters expressed in cancer cells
01/05/2006US20060003363 GLUT3 transporters expressed in cancer cells
01/05/2006US20060003362 ENT1 transporters expressed in cancer cells
01/05/2006US20060003361 SMVT transporters expressed in cancer cells
01/05/2006US20060003360 Method for analyzing variation of nucleic acid and method for analyzing gene expression
01/05/2006US20060003359 Methods of screening for cell proliferation or neoplastic disorders
01/05/2006US20060003358 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/05/2006US20060003357 Solid phase technique for selectively isolating nucleic acids
01/05/2006US20060003356 Compositions and methods for the diagnosis and treatment of kidney disease
01/05/2006US20060003355 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/05/2006US20060003354 Methods and compositions for the diagnosis of Cornelia de Lange Syndrome
01/05/2006US20060003353 Incubate with primer, polymerase and nucleotide triphosphates, amplify sequences, digest, ligate and recover; cloning
01/05/2006US20060003352 Mass tag PCR for mutliplex diagnostics
01/05/2006US20060003351 Ligation-based methods and kits are disclosed for identifying at least two target nucleotides in a mixed population sample
01/05/2006US20060003350 Methods and compositions to detect bacteria using multiplex PCR
01/05/2006US20060003349 Tm leveling compositions
01/05/2006US20060003348 Omi PDZ modulators
01/05/2006US20060003347 Single-molecule in vitro evolution
01/05/2006US20060003346 Method for treating hepatitis
01/05/2006US20060003345 RNA bioassay
01/05/2006US20060003344 Methods related to a single nucleotide polymorphism of the G protein coupled receptor, GPR40
01/05/2006US20060003343 Primer and probe design for efficient amplification and detection of HCV 3' non-translating region
01/05/2006US20060003342 Fetal RNA in amniotic fluid to determine gene expression in the developing fetus
01/05/2006US20060003341 Cloned genes encoding reverse transcriptase lacking RNase H activity
01/05/2006US20060003340 Multi-allelic molecular detection of SARS-associated coronavirus
01/05/2006US20060003339 Two-hybrid system
01/05/2006US20060003338 System and methods for the management and treatment of vascular graft disease
01/05/2006US20060003337 Detection of small RNAS
01/05/2006US20060003336 One-step enzymatic and amine detection technique
01/05/2006US20060003335 Methods for diagnosing acute megakaryoblastic leukemia
01/05/2006US20060003334 Protein (poly)peptides libraries
01/05/2006US20060003333 Preparation of defined highly labeled probes
01/05/2006US20060003332 Method for multiplex PNA-FISH
01/05/2006US20060003331 Immobilised metal ion adsorption chromatography resin to adsorb and desorb thioated nucleotides; reduces need of organic solvents and/or high pressures
01/05/2006US20060003330 Streptococcus pneumoniae pbp2x mini-protein and uses thereof
01/05/2006US20060003329 Treating cancer
01/05/2006US20060003328 Method and system for enhancing data quality
01/05/2006US20060003327 Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
01/05/2006US20060003326 Bioconjugation; spiegelmers, aptamers
01/05/2006US20060003325 Method of detecting base mutation
01/05/2006US20060003324 Method for producing gene libraries
01/05/2006US20060003323 NOVX nucleic acids and their encoded polypeptides; diagnostic and therapeutic applications in the detection of a variety of diseases with differential expression in normal vs. diseased tissues, e.g., detection of a variety of cancers.
01/05/2006US20060003322 a nucleotide sequence of a first half of said RNA precursor is a partial inversed-reversed sequence of a nucleotide sequence of a second half
01/05/2006US20060003321 Expression monitoring for human cytomegalovirus (HCMV) infection
01/05/2006US20060003320 Exploring fluorophore microenvironments
01/05/2006US20060003319 Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays
01/05/2006US20060003318 Influenza sensor
01/05/2006US20060003317 Drug discovery method
01/05/2006US20060003316 Immunogenic compositions derived from poxviruses and methods of using same
01/05/2006US20060003315 Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes
01/05/2006US20060003314 Methods for peptide and protein display in nucleic acid arrays
01/05/2006US20060003313 For differentiating cells in a cell population comprising pancreatic-duodenal homeobox factor-1 (PDX1) positive (PDX1-expressing) endoderm cells and/or PDX1-negative endoderm cells; cell therapy
01/05/2006US20060003312 Circulating stem cells and uses related thereto
01/05/2006US20060003311 In vitro screening of cellular events using 3d cell culture systems
01/05/2006US20060003310 Device for performing cell assays
01/05/2006US20060003029 Method for monitoring the quality of a herbal medicine
01/05/2006US20060002993 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response
01/05/2006US20060002957 Method and device for detecting feline immunodeficiency virus
01/05/2006US20060002953 Molecular differences between species of the M. tuberculosis complex
01/05/2006US20060002952 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
01/05/2006US20060002951 Inhibition of the tRNALys3-primed initiation of reverse transcription in HIV-1 by APOBEC3G
01/05/2006US20060002950 Immunomodulatory protein derived from Trypanosomes and uses thereof
01/05/2006US20060002939 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions
01/05/2006US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators)
01/05/2006US20060002901 Composition containing eosinophil cationic protein
01/05/2006US20060002892 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor
01/05/2006US20060000758 Reacting an inorganic support with acetoxy alkyltriethoxysilane and a linker; reacting the linker with a catalyst; reducing non-specific binding to an inorganic support; high activity, selectivity, easily recovered from reaction solutions for subsequent reuse
01/05/2006DE10226675B4 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances
01/05/2006DE10226674B4 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances
01/05/2006DE102004050575B3 Verfahren zur kombinierten Isolierung von Magnet-Beads aus einer flüssigen Probe und anschließender Thermozyklisierung für die PCR und zugehörige Anordnung Process for the combined isolation of magnetic beads from a liquid sample and subsequent thermocycling for PCR and related assembly
01/05/2006DE102004029470A1 Verfahren zur Bestimmung von Aggrekanase-Aktivitäten Method for determination of aggrecanase activity
01/05/2006DE102004027661A1 Antriebsanordnung für ein Robotsystem, insbesondere zur Ausführung von automatischen Manipulationen im Bereich der Isolierung und Behandlung von Zellklonen und Einzelzellen A drive arrangement for a robot system, in particular for the execution of automatic manipulations in the area of ​​isolating and treating cell clones and single cells
01/05/2006CA2613311A1 Improvements in and relating to micro-organism test apparatus and methods of using the same
01/05/2006CA2591610A1 Methods for predicting methotrexate polyglutamate levels using pharmacogenetics
01/05/2006CA2589563A1 Method of screening compound directly activating glycogen synthase
01/05/2006CA2577600A1 Method for electrochemically measuring phosphoric acid and/or phosphate ester
01/05/2006CA2572338A1 Methods and reagents for the detection of melanoma
01/05/2006CA2572176A1 Probe optimization methods
01/05/2006CA2572155A1 Cell network analysis system
01/05/2006CA2571567A1 Variable length probe selection
01/05/2006CA2571332A1 Methods of oligosaccharide profiling for the detection of cancer